161 related articles for article (PubMed ID: 30004939)
1. 18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.
Singhal T; OʼConnor K; Dubey S; Belanger AP; Hurwitz S; Chu R; Tauhid S; Kijewski MF; DiCarli MF; Weiner HL; Bakshi R
Clin Nucl Med; 2018 Sep; 43(9):e289-e295. PubMed ID: 30004939
[TBL] [Abstract][Full Text] [Related]
2. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
4. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
[TBL] [Abstract][Full Text] [Related]
5. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
[TBL] [Abstract][Full Text] [Related]
6.
Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Zeydan B; Schwarz CG; Przybelski SA; Lesnick TG; Kremers WK; Senjem ML; Kantarci OH; Min PH; Kemp BJ; Jack CR; Kantarci K; Lowe VJ
J Nucl Med; 2022 Aug; 63(8):1239-1244. PubMed ID: 34916245
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography.
Dickstein LP; Zoghbi SS; Fujimura Y; Imaizumi M; Zhang Y; Pike VW; Innis RB; Fujita M
Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):352-7. PubMed ID: 21085954
[TBL] [Abstract][Full Text] [Related]
9. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
[TBL] [Abstract][Full Text] [Related]
10. Reduced [
Moscoso A; Grothe MJ; Schöll M;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
[TBL] [Abstract][Full Text] [Related]
12. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
[TBL] [Abstract][Full Text] [Related]
13. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
16. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
[TBL] [Abstract][Full Text] [Related]
18. Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage.
Pietroboni AM; Colombi A; Carandini T; Sacchi L; Fenoglio C; Marotta G; Arighi A; De Riz MA; Fumagalli GG; Castellani M; Bozzali M; Scarpini E; Galimberti D
Alzheimers Res Ther; 2022 Feb; 14(1):33. PubMed ID: 35151361
[TBL] [Abstract][Full Text] [Related]
19. Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18 F-PBR06 Study.
Singhal T; Cicero S; Rissanen E; Ficke J; Kukreja P; Vaquerano S; Glanz B; Dubey S; Sticka W; Seaver K; Kijewski M; Callen AM; Chu R; Carter K; Silbersweig D; Chitnis T; Bakshi R; Weiner HL
Clin Nucl Med; 2024 Jun; 49(6):491-499. PubMed ID: 38630948
[TBL] [Abstract][Full Text] [Related]
20. Differences in gray and white matter
Son HJ; Oh JS; Roh JH; Seo SW; Oh M; Lee SJ; Oh SJ; Kim JS
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):357-366. PubMed ID: 30109402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
